Your browser doesn't support javascript.
loading
Pan-HDAC inhibition by panobinostat mediates chemosensitization to carboplatin in non-small cell lung cancer via attenuation of EGFR signaling.
Wang, Lingzhi; Syn, Nicholas Li-Xun; Subhash, Vinod Vijay; Any, Yijia; Thuya, Win Lwin; Cheow, Esther Sok Hwee; Kong, Liren; Yu, Fenggang; Peethala, Praveen C; Wong, Andrea Li-Ann; Laljibhai, Hirpara J; Chinnathambi, Arunachalam; Ong, Pei Shi; Ho, Paul Chi-Lui; Sethi, Gautam; Yong, Wei Peng; Goh, Boon Cher.
Afiliação
  • Wang L; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Syn NL; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Subhash VV; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Any Y; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore.
  • Thuya WL; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Cheow ESH; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Kong L; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Yu F; Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • Peethala PC; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Wong AL; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.
  • Laljibhai HJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore.
  • Chinnathambi A; Department of Botany and Microbiology, College of Science, King Saud University, Riyadh 11451, Saudi Arabia.
  • Ong PS; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore.
  • Ho PC; Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore.
  • Sethi G; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Electronic address: phcgs@nus.edu.sg.
  • Yong WP; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore. Electronic address: csiywp@nus.edu.sg.
  • Goh BC; Cancer Science Institute of Singapore, National University of Singapore, Singapore; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore. Electronic add
Cancer Lett ; 417: 152-160, 2018 03 28.
Article em En | MEDLINE | ID: mdl-29306016
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Ensaios Antitumorais Modelo de Xenoenxerto / Receptores ErbB / Neoplasias Pulmonares Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Ensaios Antitumorais Modelo de Xenoenxerto / Receptores ErbB / Neoplasias Pulmonares Idioma: En Ano de publicação: 2018 Tipo de documento: Article